retatrutide ly3437943 phase 2 trial obesity nejm 2023 𧬠R3TA is a next-generation peptide being studied for its unique triple-receptor approach to metabolic health. Unlike traditional GLP-1 therapies, R3TA is designed to interact with three metabolic pathways simultaneously: GLP-1, GIP TRIUMPH-1 Trial Results: Retatrutide for
Pay in 4 interest-free payments of $5.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 24 - Aug 29


























![Exeggutor (5/116) [Black & White: Plasma Freeze] 109](https://cdn.shopify.com/s/files/1/0586/8099/9959/files/a720e5d1-3478-4194-8953-f276981e5c14_df6d198e-e493-4274-bf4a-0933a2bb3fa5.png?v=1770334680)
